Deferasirox-Induced Serious Metabolic Abnormalities;Bicalutamide-Induced Heart Failure;Combination Ipilimumab and Nivolumab–Induced Lethal Myocarditis;Polymyxin B-Trimethoprim Eye Drop–Induced Anaphylaxis;Methylphenidate-Induced Diffuse Maculopapular Rash

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.